| Literature DB >> 31975836 |
Benalfew Legesse1, Baktash Babadi1, Brent Forester1.
Abstract
Dementias, renamed neurocognitive disorders (NCDs) in the DSM-5, are defined by acquired decline in cognitive and functional abilities. DSM-5 now also includes mild NCD, which incorporates the previous diagnosis of mild cognitive impairment. DSM-5 recognizes the following etiologies for NCDs: NCD due to Alzheimer's disease, vascular NCD, NCD with Lewy bodies, frontotemporal NCD, substance-/medication-induced NCD, NCD due to traumatic brain injury, NCD due to Huntington's disease, NCD due to HIV infection, NCD due to prion disease, and NCD due to other medical conditions. In this review, the authors discuss a wide variety of interventions that have been studied for the treatment and management of neuropsychiatric symptoms of patients with NCDs. In addition to nonpharmacological interventions, several classes of medications-including antipsychotics, antidepressants, anticonvulsants, and cholinesterase inhibitors-have been studied for this indication.Entities:
Keywords: Antidepressants; Antipsychotics; Dementia; Neurocognitive disorder; Neuropsychiatric symptoms
Year: 2017 PMID: 31975836 PMCID: PMC6519624 DOI: 10.1176/appi.focus.20160031
Source DB: PubMed Journal: Focus (Am Psychiatr Publ) ISSN: 1541-4094